Related Articles
MEK inhibitors against MET-amplified non-small cell lung cancer
Sequential use of protein kinase inhibitors potentiates their toxicity to melanoma cells: A rationale to combine targeted drugs based on protein expression inhibition profiles
Combination of SB431542, CHIR99021 and PD0325901 has a synergic effect on abrogating valproic acid‑induced epithelial‑mesenchymal transition and stemness in HeLa, 5637 and SCC‑15 cells
Towards combinatorial targeted therapy in melanoma: From pre-clinical evidence to clinical application (Review)
The combination of rapamycin and MAPK inhibitors enhances the growth inhibitory effect on Nara-H cells